Chabiotech Appoints Vice Chairman Chawontae Cha as New CEO
Board Meeting Held on March 4
On March 4, Chabiotech announced that its board of directors held a meeting and appointed Chawontae Cha, Vice Chairman of CHA Medical Center and CHA Bio Group and Chief Sustainability Officer (CSO), as the new CEO.
CEO Cha previously served as Chief Operating Officer (COO) of CHA Health Systems, which operates CHA Hollywood Presbyterian Medical Center in the United States, and as Chief Strategy Officer (CSO) of CHA Hollywood Presbyterian Medical Center. He later served as President of CHA University.
He graduated from the Department of Biological Anatomy at Duke University in the United States. He holds a Master of Public Health (MPH) from Yale University and a Master of Business Administration (MBA) from the Massachusetts Institute of Technology (MIT). He earned a Ph.D. in Public Health from Yonsei University.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Since September last year, CEO Cha has served as Vice Chairman of CHA Medical Center and CHA Bio Group and CSO of Chabiotech, overseeing the establishment of the group’s ESG management system and growth strategies for its affiliates. In January this year, he was appointed as an inside director of Chabiotech to strengthen responsible management.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.